US 12083227
Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
granted A61KA61K31/513A61K9/2009
Quick answer
US patent 12083227 (Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis) held by Neurocrine Biosciences, Inc. expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61K, A61K31/513, A61K9/2009, A61K9/2013, A61K9/2027